Roxy is a modern hybrid cannabis strain developed through the crossbreeding of two distinct lineages: a European hybrid and Casey Jones. This genetic pairing was specifically engineered to produce a high-yielding plant that performs well in both indoor and outdoor cultivation environments. With a flowering cycle of 60 days, the strain is classified as having a moderate difficulty level, making it a functional choice for growers seeking a balance between refined cultivation requirements and substantial output.

The chemical profile of Roxy is defined by an extensive terpene expression, led by a dominant concentration of myrcene, followed by limonene and caryophyllene. This profile transitions into subtler notes provided by nerolidol, beta-pinene, and linalool, with traces of pinene, humulene, and camphene rounding out the complex aroma, finishing with a final touch of terpinolene. This intricate collection of volatile compounds results in a multifaceted sensory experience that informs the strain's overall bouquet and flavor profile.

As a THC-dominant hybrid, Roxy is best known for its ability to induce feelings of relaxation, happiness, and an uplifted mood. Consequently, it is frequently utilized by patients seeking relief from symptoms of stress, chronic pain, and sleep disturbances. Beyond its immediate therapeutic utility, the strain has demonstrated its genetic viability as a parent in its own right, most notably contributing to the development of the offspring variety Rozzilla.